Nutraceuticals and Functional Foods Institute (INAF), Laval University, Québec, Canada.
Mol Genet Metab. 2012 Mar;105(3):494-501. doi: 10.1016/j.ymgme.2011.11.198. Epub 2011 Dec 2.
Obese individuals are characterized by a chronic, low-grade inflammatory state. Increased levels of C-reactive protein (CRP), a marker of inflammation, have been observed in subjects with the metabolic syndrome. We have previously reported that genes encoding proteins involved in the anti-inflammatory and immune response are differentially expressed in visceral adipose tissue of obese men with or without the metabolic syndrome. Among these genes, the interferon-gamma-inducible protein 30 (IFI30), CD163 molecule (CD163), chemokine (C-X-C motif) ligand 9 (CXCL9) and thymic stromal lymphopoietin (TSLP), were selected for further genetic analyses. The aim of the study was to verify whether IFI30, CD163, CXCL9 and TSLP gene polymorphisms contribute to explain the inter-individual variability of the inflammatory profile of obesity assessed by plasma high-sensitivity CRP concentrations. A total of 1185 severely obese individuals were genotyped for single nucleotide polymorphisms (SNPs) covering most of the sequence-derived genetic variability at the IFI30, CD163, CXCL9 and TSLP gene loci (total of 27 SNPs). Following measurement of plasma CRP levels, subjects were divided into two groups, low vs. high using the median value of plasma CRP levels (8.31 mg/L) as a cutoff point. Genotype frequencies were compared between groups. Associations between genotypes and plasma CRP levels (continuous variable) were also tested after adjustments for age, sex, smoking and BMI. The rs11554159 and rs7125 IFI30 SNPs showed a significant difference in genotype frequencies (p<0.05) between subgroups of low vs. high plasma CRP levels (wild type homozygotes: rs11554159=47% vs. 55%, rs7125=31% vs. 24%, for low vs. high CRP groups, respectively). The association between rs11554159 and CRP levels as a continuous variable remained significant (p=0.004). Both carriers of the GA and AA genotypes demonstrated, on average, a 13% lower CRP levels in comparison with GG homozygotes. No association was observed between SNPs in the CD163, CXCL9 and TSLP genes and CRP levels. The IFI30 rs11554159 polymorphism could partially explain the inter-individual variability observed in the inflammatory profile associated with obesity.
肥胖个体的特征是慢性低度炎症状态。代谢综合征患者的 C 反应蛋白(CRP)水平升高,这是炎症的标志物。我们之前曾报道过,编码参与抗炎和免疫反应的蛋白质的基因在肥胖男性的内脏脂肪组织中差异表达,无论他们是否患有代谢综合征。在这些基因中,干扰素-γ诱导蛋白 30(IFI30)、CD163 分子(CD163)、趋化因子(C-X-C 基序)配体 9(CXCL9)和胸腺基质淋巴生成素(TSLP)被选择用于进一步的遗传分析。本研究的目的是验证 IFI30、CD163、CXCL9 和 TSLP 基因多态性是否有助于解释通过血浆高敏 CRP 浓度评估的肥胖炎症特征的个体间变异性。共对 1185 名严重肥胖个体进行了单核苷酸多态性(SNP)基因分型,这些 SNP 覆盖了 IFI30、CD163、CXCL9 和 TSLP 基因座的序列衍生遗传多态性的大部分(共 27 个 SNP)。在测量血浆 CRP 水平后,根据血浆 CRP 水平的中位数(8.31mg/L)将受试者分为低和高两组。比较两组之间的基因型频率。在调整年龄、性别、吸烟和 BMI 后,还测试了基因型与血浆 CRP 水平(连续变量)之间的关联。IFI30 基因的 rs11554159 和 rs7125 位点的基因型频率在低 vs. 高 CRP 水平亚组之间存在显著差异(p<0.05)(野生型纯合子:rs11554159=47% vs. 55%,rs7125=31% vs. 24%,分别用于低 vs. 高 CRP 组)。rs11554159 与 CRP 水平作为连续变量之间的关联仍然显著(p=0.004)。与 GG 纯合子相比,GA 和 AA 基因型携带者的 CRP 水平平均降低了 13%。在 CD163、CXCL9 和 TSLP 基因的 SNP 与 CRP 水平之间未观察到相关性。IFI30 rs11554159 多态性可能部分解释了与肥胖相关的炎症特征的个体间变异性。